What does it mean for you
Comparison with other GLP-1 medications Different GLP-1 receptor agonists have different stability profiles: Tirzepatide (Mounjaro/Zepbound): Similar storage requirements to semaglutide
Furthermore, following the 2008 US Food and Drug Administration (FDA) guidance for industry that requires proof of cardiovascular safety as a prerequisite for approval of diabetes treatments, there has been a substantial increase in the understanding of the risks of these treatments, in addition to their benefits, on clinically relevant outcomes
Rising awareness of the cardiovascular and renal benefits associated with GLP-1 receptor agonists has also contributed to their expanding utilization
Additionally, many GLP-1 users take proton pump inhibitors for acid reflux, which research shows can significantly deplete magnesium stores (PMID: 39279305)
Strong or unusual odors indicate bacterial growth